SI1435976T1 - Farmacevtski sestavek, ki obsega hito-oligomere - Google Patents
Farmacevtski sestavek, ki obsega hito-oligomereInfo
- Publication number
- SI1435976T1 SI1435976T1 SI200230558T SI200230558T SI1435976T1 SI 1435976 T1 SI1435976 T1 SI 1435976T1 SI 200230558 T SI200230558 T SI 200230558T SI 200230558 T SI200230558 T SI 200230558T SI 1435976 T1 SI1435976 T1 SI 1435976T1
- Authority
- SI
- Slovenia
- Prior art keywords
- oligomers
- chito
- treatment
- pharmaceutical composition
- compositions
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 208000012659 Joint disease Diseases 0.000 abstract 2
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 abstract 2
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 abstract 2
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 229950006780 n-acetylglucosamine Drugs 0.000 abstract 2
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 abstract 1
- 229920002101 Chitin Polymers 0.000 abstract 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 abstract 1
- 230000006196 deacetylation Effects 0.000 abstract 1
- 238000003381 deacetylation reaction Methods 0.000 abstract 1
- 229960002442 glucosamine Drugs 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 201000008482 osteoarthritis Diseases 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
- C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
- C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Polymers & Plastics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Materials Engineering (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IS6085A IS6085A (is) | 2001-09-26 | 2001-09-26 | Lyfjablanda með kítósan óligómerum |
| EP02777769A EP1435976B1 (en) | 2001-09-26 | 2002-09-26 | Pharmaceutical composition comprising chito-oligomers |
| PCT/IS2002/000016 WO2003026677A1 (en) | 2001-09-26 | 2002-09-26 | Pharmaceutical composition comprising chito-oligomers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1435976T1 true SI1435976T1 (sl) | 2007-08-31 |
Family
ID=36700489
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200230558T SI1435976T1 (sl) | 2001-09-26 | 2002-09-26 | Farmacevtski sestavek, ki obsega hito-oligomere |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US7985741B2 (https=) |
| EP (1) | EP1435976B1 (https=) |
| JP (1) | JP4613008B2 (https=) |
| KR (1) | KR20040062548A (https=) |
| AT (1) | ATE359797T1 (https=) |
| CA (1) | CA2507926C (https=) |
| DE (1) | DE60219653T2 (https=) |
| DK (1) | DK1435976T3 (https=) |
| ES (1) | ES2284935T3 (https=) |
| IS (2) | IS6085A (https=) |
| PT (1) | PT1435976E (https=) |
| SI (1) | SI1435976T1 (https=) |
| WO (1) | WO2003026677A1 (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003054208A2 (en) * | 2001-12-13 | 2003-07-03 | Ism Biopolymer Inc. | Method of modulating release of saccharides and uses thereof |
| GB0321996D0 (en) * | 2003-09-19 | 2003-10-22 | Novartis Nutrition Ag | Organic compounds |
| EP1670486A4 (en) * | 2003-10-01 | 2009-04-01 | Optimer Pharmaceuticals Inc | TREATMENT OF A CONDITION IN A MAMMALIAN WITH ADMINISTRATION OF AMINO SUGAR AND USES THEREOF |
| US20070082851A1 (en) * | 2003-11-24 | 2007-04-12 | Optimer Pharmaceuticals Inc. | Treatment of a condition in a mammal with administration of Compounds and Methods of Use |
| WO2005112948A1 (ja) * | 2004-05-21 | 2005-12-01 | Tottori University | 創傷の治療又は処置のための薬剤 |
| AU2006257177A1 (en) * | 2005-06-14 | 2006-12-21 | Genis Ehf. | Compositions of partially deacetylated chitin derivatives |
| WO2007001282A2 (en) * | 2005-06-16 | 2007-01-04 | E.I. Dupont De Nemours And Company | Low molecular weight polyglucosamines and polygalactosamines |
| US7485718B2 (en) | 2005-06-16 | 2009-02-03 | E. I. Du Pont De Nemours And Company | Chemical synthesis of low molecular weight polyglucosamines and polygalactosamines |
| KR100831335B1 (ko) * | 2006-06-22 | 2008-05-22 | 부경대학교 산학협력단 | 인간 피부 섬유아세포에서 메트릭스메탈로프로테이나제-2의 발현 및 활성을 억제시키는키토올리고사카라이드 화합물 및 이를 함유한 메트릭스메탈로프로테이나제-2 억제제 |
| EP2318014B1 (en) * | 2008-07-18 | 2016-09-14 | Genís hf. | New composition for treating autoimmune disorders |
| KR20100060634A (ko) * | 2008-11-28 | 2010-06-07 | (주)아모레퍼시픽 | 미토콘드리아 활성화를 위한 조성물 |
| KR101729137B1 (ko) * | 2009-07-28 | 2017-04-26 | (주)아모레퍼시픽 | 키토올리고당을 함유하는 피로회복용 조성물 |
| JP6141265B2 (ja) | 2011-06-03 | 2017-06-07 | マグワイア アビー， エルエルシー | 関節の潤滑性を改善するための方法、組成物及び物品 |
| AR090026A1 (es) | 2011-09-08 | 2014-10-15 | Novozymes Bioag As | Metodos y composiciones para tratamiento de semillas |
| ES2970761T3 (es) | 2011-09-14 | 2024-05-30 | Novozymes Bioag As | Uso de lipoquitooligosacáridos y/o quitooligosacáridos en combinación con microorganismos solubilizadores de fosfato para potenciar el crecimiento de las plantas |
| RU2564844C1 (ru) | 2011-09-23 | 2015-10-10 | Новозимс Биоаг А/С | Хитоолигосахариды и способы их применения для усиления роста растений |
| AU2012312006B2 (en) * | 2011-09-23 | 2015-10-29 | Novozymes Bioag A/S | Chitooligosaccharides and methods for use in enhancing corn growth |
| JP6232048B2 (ja) | 2012-04-23 | 2017-11-15 | ジェニス エイチエフ． | 骨移植片代用材としての部分的に脱アセチル化されたキチンを含む自硬性の生体活性セメント組成物 |
| JP6285497B2 (ja) * | 2016-06-07 | 2018-02-28 | 株式会社エバーライフ | 鶏冠抽出物含有経口組成物及び鶏冠抽出物の香味に由来する摂取困難性の改善方法 |
| KR101673368B1 (ko) | 2016-07-14 | 2016-11-08 | 김기혁 | 공정가스 반응물의 콜드트랩 장치 |
| CA3256512A1 (en) * | 2022-04-21 | 2023-10-26 | Therapeutikos, Inc. | METHODS OF TREATING INFLAMMATION |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5919122B2 (ja) * | 1976-10-12 | 1984-05-02 | 味の素株式会社 | 水溶性部分脱アセチル化キチン及びその製造法 |
| US4532134A (en) * | 1981-04-06 | 1985-07-30 | Malette William Graham | Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound |
| JP2527317B2 (ja) * | 1986-12-19 | 1996-08-21 | ライオン株式会社 | 骨疾患治療剤 |
| US6184037B1 (en) * | 1996-05-17 | 2001-02-06 | Genemedicine, Inc. | Chitosan related compositions and methods for delivery of nucleic acids and oligonucleotides into a cell |
| CA2274510C (en) * | 1996-12-13 | 2010-02-16 | Lescarden, Inc. | Treatment of osteoarthritis by administering poly-n-acetyl-d-glucosamine |
| JP3062592B2 (ja) * | 1997-05-30 | 2000-07-10 | 農林水産省食品総合研究所長 | ２−アセチルアミノ−４−Ｏ−（２−アミノ−２−デオキシ−β−Ｄ −グルコピラノシル）−２−デオキシ−Ｄ −グルコースおよびその塩の製造法 |
| US6492350B2 (en) * | 2000-01-27 | 2002-12-10 | Jdc (Hawaii) Inc. | Chitin oligosaccharides and/or chitosan oligosaccharides for preventing or treating common cold or treating pain |
| EP1127574A1 (en) * | 2000-02-22 | 2001-08-29 | Food Industry Research and Development Institute | Use of chitinous materials for inhibiting cellular nitric oxide production |
| CA2313836C (en) * | 2000-03-15 | 2009-06-09 | Cargill, Incorporated | Chitosan and method of preparing chitosan |
| US20020119949A1 (en) * | 2001-02-26 | 2002-08-29 | Asa Hellman | Prophylactic teat treatment |
| AU2006257177A1 (en) * | 2005-06-14 | 2006-12-21 | Genis Ehf. | Compositions of partially deacetylated chitin derivatives |
-
2001
- 2001-09-26 IS IS6085A patent/IS6085A/is unknown
-
2002
- 2002-09-26 EP EP02777769A patent/EP1435976B1/en not_active Expired - Lifetime
- 2002-09-26 US US10/490,637 patent/US7985741B2/en active Active
- 2002-09-26 DK DK02777769T patent/DK1435976T3/da active
- 2002-09-26 KR KR10-2004-7004323A patent/KR20040062548A/ko not_active Ceased
- 2002-09-26 JP JP2003530312A patent/JP4613008B2/ja not_active Expired - Lifetime
- 2002-09-26 AT AT02777769T patent/ATE359797T1/de active
- 2002-09-26 PT PT02777769T patent/PT1435976E/pt unknown
- 2002-09-26 DE DE60219653T patent/DE60219653T2/de not_active Expired - Lifetime
- 2002-09-26 WO PCT/IS2002/000016 patent/WO2003026677A1/en not_active Ceased
- 2002-09-26 SI SI200230558T patent/SI1435976T1/sl unknown
- 2002-09-26 CA CA2507926A patent/CA2507926C/en not_active Expired - Lifetime
- 2002-09-26 ES ES02777769T patent/ES2284935T3/es not_active Expired - Lifetime
-
2004
- 2004-03-22 IS IS7193A patent/IS2783B/is unknown
-
2011
- 2011-06-20 US US13/164,397 patent/US8415326B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| IS2783B (is) | 2012-05-15 |
| US7985741B2 (en) | 2011-07-26 |
| DK1435976T3 (da) | 2007-08-27 |
| EP1435976B1 (en) | 2007-04-18 |
| EP1435976A1 (en) | 2004-07-14 |
| JP2005507891A (ja) | 2005-03-24 |
| ATE359797T1 (de) | 2007-05-15 |
| US20050004073A1 (en) | 2005-01-06 |
| CA2507926A1 (en) | 2003-04-03 |
| KR20040062548A (ko) | 2004-07-07 |
| ES2284935T3 (es) | 2007-11-16 |
| WO2003026677A1 (en) | 2003-04-03 |
| US20110257381A1 (en) | 2011-10-20 |
| CA2507926C (en) | 2011-12-20 |
| JP4613008B2 (ja) | 2011-01-12 |
| IS7193A (is) | 2004-03-22 |
| IS6085A (is) | 2003-03-27 |
| US8415326B2 (en) | 2013-04-09 |
| DE60219653D1 (de) | 2007-05-31 |
| DE60219653T2 (de) | 2008-01-03 |
| PT1435976E (pt) | 2007-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI1435976T1 (sl) | Farmacevtski sestavek, ki obsega hito-oligomere | |
| IL150257A0 (en) | Galactomaninan oligosaccharides, pharmaceutical compositions containing the same and methods for the production thereof | |
| CA2303498A1 (en) | Dioxocyclopentyl hydroxamic acids | |
| EP2085780A3 (en) | Methods and products related to low molecular weight heparin | |
| EP2497478A3 (en) | Oligosaccaride compositions and use thereof in the treatment of infection | |
| WO2004034980A3 (en) | Treatment for traumatic synovitis and damaged articular cartilage | |
| AU2003901834A0 (en) | Cross-linked polysaccharide compositions | |
| MXPA04001876A (es) | Uso de fucanos en el tratamiento de adhesiones, artritis y psoriasis. | |
| AU5062299A (en) | Formulations of anionic polysaccharides | |
| WO2004105737A3 (en) | Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents | |
| MY142376A (en) | Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them | |
| ES2161615A1 (es) | Composiciones de heparinas de muy bajo peso molecular. | |
| IL172773A (en) | Formulations for the treatment of arthritis conditions | |
| IL157050A0 (en) | 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry | |
| PL346143A1 (en) | Tan-1057 derivatives | |
| TW200510012A (en) | Aqua gel comprising temperature effect | |
| ATE388717T1 (de) | Mittel zur bekämpfung von entzündungen und/oder degenerativen erkrankungen | |
| ITMI20021801A1 (it) | Prodotti di pomodoro. | |
| IL126998A (en) | Potassium, sodium or tris oxaprozin salt pharmaceutical formulations | |
| EP2301554A8 (en) | Composition for the treatment of osteoarthritis | |
| EP1411956B8 (en) | Use of oversulfated polysaccharides as inhibitors of hiv | |
| CA2416369A1 (fr) | Utilisation de cyclodextrines polysulfatees pour le traitement de l'arthrose | |
| ATE552004T1 (de) | Oral verabreichbare heparinderivate | |
| WO2002068056A3 (en) | Combination comprising a 1,4-dioxonaphathalene compound and ribenoside | |
| WO2000029433A3 (en) | 12-25-kda bacterial proteins and their 116-58 kda polymers for use e.g. in anti-tumor vaccines |